Research
Discover our commitment to advancing Dry AMD treatment through research.
Woman, 68 y/o, AREDS 3
Man, 55 y/o, Non-Neovascular AMD
2024 Bryn Mawr Communications
Randomized Multicenter Trial
13-Month Efficacy and Safety Evaluation of Multiwavelength Photobiomodulation
A randomised clinical trial evaluated multiwavelength PBM in patients with dry AMD
Your Cart is Empty
Loading...